| Financial Year |
March 31 2023 |
| Monetary Funds |
138,723,438.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,925,793.83 |
| Accounts Receivable |
626,866,468.12 |
| Advances to Suppliers |
21,521,619.03 |
| Other Receivables |
140,595,226.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,340,809.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,214,149.28 |
| Total Current Assets |
1,935,602,405.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
48,585,248.29 |
| Investment Properties |
400,097,202.00 |
| Fixed Assetes |
76,340,890.36 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,930,140.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,021,785.76 |
| Deferred Income Tax Assets |
4,305,406.67 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
547,171,026.56 |
| Total Assets |
2,482,773,432.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
867,259,362.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,989,152.92 |
| Taxes Payable |
179,529,848.56 |
| Interest Payable |
107,339,802.17 |
| Dividend Payable |
-- |
| Other payables |
1,599,733,092.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,849,266.18 |
| Other Current Liabilities |
52,894,902.59 |
| Sub-Total of Current Liabilities |
2,763,031,047.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
211,198,945.95 |
| Deferred Income Tax Liabilities |
59,974,138.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
275,298,963.26 |
| Total Liabilities |
3,038,330,011.13 |
| Paid-In Capital(Or Share Stock) |
225,000,000.00 |
| Capital Surplus |
709,012,036.62 |
| Surplus Reserve |
120,636,936.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,588,599,200.19 |
| Minority Stockholder's Interest |
-23,245,259.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-532,311,318.75 |
| Owner's Equity（Stockholder's Equity） |
-555,556,578.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,482,773,432.40 |
